Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX7 | Q99572 | 14/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30157647 | 0.90 | P2RX7 (0.67) | P2RX7ALDH1A1LMNAMAPTHTT | |
| SCHEMBL30157559 | 0.87 | EPHX2 (0.54) | P2RX7ALDH1A1HPGDLMNAHTT | |
| SCHEMBL30158073 | 0.84 | P2RX7 (0.61) | P2RX7ALDH1A1LMNAMAPTHTT | |
| SCHEMBL30157654 | 0.84 | P2RX7 (0.52) | P2RX7ALDH1A1HPGDLMNAHTT | |
| SCHEMBL30157943 | 0.83 | P2RX7 (0.56) | P2RX7ALDH1A1LMNAMAPTHTT | |
| SCHEMBL30157960 | 0.83 | P2RX7 (0.53) | P2RX7ALDH1A1LMNAMAPTHTT | |
| SCHEMBL30158106 | 0.83 | P2RX7 (0.51) | P2RX7ALDH1A1HPGDLMNAMAPT | |
| SCHEMBL30157728 | 0.82 | P2RX7 (0.64) | P2RX7ALDH1A1LMNAMAPTHTT | |
| SCHEMBL30157608 | 0.82 | P2RX7 (0.67) | P2RX7ALDH1A1LMNAMAPTHTT | |
| SCHEMBL30157585 | 0.81 | HTT (0.58) | ALDH1A1MAPTHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022268520-A1 | USE OF SUBSTITUTED PYRROLIDINONES OR THEIR SALTS FOR INCREASING STRESS TOLERANCE OF PLANTS | BAYER AKTIENGESELLSCHAFT (DE) | 2022-12-29 | — | — | WO | disclosed |